Skip to Content
Home > Wellness > Health Library > Erythropoietin Stimulating Agents
Erythropoietin stimulating agents can be given two ways. They may
be injected into a vein with an intravenous (IV) needle or injected under the
skin (subcutaneous). Talk to your doctor about which way is best for you.
Erythropoietin stimulating agents cause the bone
marrow to produce more red blood cells, and they decrease your need for blood
transfusions. Anemia often occurs because of a decrease in
erythropoietin, a hormone produced by the kidneys.
Injections of erythropoietin stimulating agents replace this hormone.
Erythropoietin stimulating agents replace the
erythropoietin normally made by the kidneys. Therapy with erythropoietin stimulating agents may be used to treat anemia:
Erythropoietin stimulating agents treat
anemia by increasing the number of new red blood cells your body makes. This
may decrease your need for blood transfusions. Your dose of an erythropoietin stimulating agent may need to be adjusted so that you can keep a certain red blood cell count
Things that may make this therapy less effective
High blood pressure can develop during treatment with erythropoietin stimulating agents.
It may be
dangerous to use erythropoietin stimulating agents to increase your red blood cell
(hemoglobin) levels above 12 g/dL. Hemoglobin levels that are too high may
increase your risk for death, heart failure, heart attack, and stroke. Talk
with your doctor about your concerns. And keep all your appointments for blood
See Drug Reference for a full list of side
effects. (Drug Reference is not available in all systems.)
Most people do not have problems
with erythropoietin stimulating agents. They can help improve how well you feel and
increase your appetite, energy, and activity levels.
Erythropoietin therapy is expensive.
Your doctor may need to make adjustments in your dose to find the amount that
gives you the most benefit but costs the least.
Complete the new medication information form (PDF)new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
September 15, 2011
Anne C. Poinier, MD - Internal Medicine & Mitchell H. Rosner, MD - Nephrology
How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2013 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
250 Pleasant Street
Concord, NH 03301
Contact Concord Hospital
View Quality Data
© 2014 Concord Hospital